Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.…
Pro-Dex (PDEX) Positioned for Growth as Zimmer Advances Robotic Knee Platform
Pro-Dex (NASDAQ: PDEX) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 201 employees.
The shares were at 63.00 USD on 20 November 2026, up 93.3% over 52 weeks. Its 52-week range is 28.81 USD to 77.00 USD: the price is 18.2% below the high and 118.7% above the low.
At a market capitalisation of 201.60M USD, it trades at 17.4 times trailing earnings and 18.2 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, a discount of 64% for PDEX.
Pro-Dex reports return on equity of 28.7%, an operating margin of 16.8% and revenue up 11.0% year over year.
Its debt exceeds its cash by 5.99M USD, a debt-to-equity ratio of 0.40. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 80.00 USD is 27.0% above the current price. The next earnings report is expected on 28 January 2027.